BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17403527)

  • 1. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer.
    Bendesky A; Rosales A; Salazar AM; Sordo M; Peniche J; Ostrosky-Wegman P
    Mutat Res; 2007 Jun; 619(1-2):38-44. PubMed ID: 17403527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XPA, haplotypes, and risk of basal and squamous cell carcinoma.
    Miller KL; Karagas MR; Kraft P; Hunter DJ; Catalano PJ; Byler SH; Nelson HH
    Carcinogenesis; 2006 Aug; 27(8):1670-5. PubMed ID: 16513681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.
    Liu G; Miller DP; Zhou W; Thurston SW; Fan R; Xu LL; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Res; 2001 Dec; 61(24):8718-22. PubMed ID: 11751390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
    Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
    J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
    Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
    Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.
    Queille S; Luron L; Spatz A; Avril MF; Ribrag V; Duvillard P; Hiesse C; Sarasin A; Armand JP; Daya-Grosjean L
    Carcinogenesis; 2007 Mar; 28(3):724-31. PubMed ID: 17065198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage and repair in gastric cancer--a correlation with the hOGG1 and RAD51 genes polymorphisms.
    Poplawski T; Arabski M; Kozirowska D; Blasinska-Morawiec M; Morawiec Z; Morawiec-Bajda A; Klupińska G; Jeziorski A; Chojnacki J; Blasiak J
    Mutat Res; 2006 Oct; 601(1-2):83-91. PubMed ID: 16843501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression.
    Wang LE; Li C; Strom SS; Goldberg LH; Brewster A; Guo Z; Qiao Y; Clayman GL; Lee JJ; El-Naggar AK; Prieto VG; Duvic M; Lippman SM; Weber RS; Kripke ML; Wei Q
    Clin Cancer Res; 2007 Nov; 13(21):6532-9. PubMed ID: 17975167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin.
    Thirumaran RK; Bermejo JL; Rudnai P; Gurzau E; Koppova K; Goessler W; Vahter M; Leonardi GS; Clemens F; Fletcher T; Hemminki K; Kumar R
    Carcinogenesis; 2006 Aug; 27(8):1676-81. PubMed ID: 16501254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of apoptosis in basal cell and squamous cell carcinoma formation.
    Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
    Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage, oxidative mutagen sensitivity, and repair of oxidative DNA damage in nonmelanoma skin cancer patients.
    Bendesky A; Michel A; Sordo M; Calderón-Aranda ES; Acosta-Saavedra LC; Salazar AM; Podoswa N; Ostrosky-Wegman P
    Environ Mol Mutagen; 2006 Aug; 47(7):509-17. PubMed ID: 16673411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
    Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
    Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].
    Suárez-Rincón AE; Morán-Moguel MC; Montoya-Fuentes H; Gallegos-Arreola MP; Sánchez-Corona J
    Ginecol Obstet Mex; 2002 Jul; 70():344-8. PubMed ID: 12221910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
    Lu J; Wang LE; Xiong P; Sturgis EM; Spitz MR; Wei Q
    Carcinogenesis; 2007 May; 28(5):988-94. PubMed ID: 17118968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
    Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
    Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma.
    Yang W; Zhang Y; Tian X; Ning T; Ke Y
    Mol Carcinog; 2008 Feb; 47(2):100-4. PubMed ID: 17918207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death.
    Bonafé M; Salvioli S; Barbi C; Trapassi C; Tocco F; Storci G; Invidia L; Vannini I; Rossi M; Marzi E; Mishto M; Capri M; Olivieri F; Antonicelli R; Memo M; Uberti D; Nacmias B; Sorbi S; Monti D; Franceschi C
    Cell Death Differ; 2004 Sep; 11(9):962-73. PubMed ID: 15131588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.